Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 79

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 79
---
 increase (decrease) our pro forma as adjusted net tangible book value by approximately $and the dilution per share to new investors in this offering by $, assuming that the public offering price per share and accompanying Common Stock Warrants remains the same and after deducting Placement Agent fees and commissions and estimated offering expenses payable by us. The above discussion and table is based on 522,223shares of common stock outstanding on December 31, 2024, and excludes the following: •10,142shares of our common stock reserved for issuance under our 2021 Equity Incentive Plan; •3shares of our common stock reserved for the issuance of Rollover RSUs; •64shares issuable upon exercise of stock options outstanding under our 2021 Equity Incentive Plan; •7shares of our common stock reserved for the issuance of Rollover Warrants, with an exercise price of $45,070.73 per share; •176shares of our common stock issuable upon the exercise of the Class A Common Stock Warrants, with an exercise price of $55,272.00 per share; •497shares of our common stock issuable upon the exercise of the Class B Common Stock Warrants, with an exercise price of $10,080.00 per share; •35shares of our common stock issuable upon the exercise of the Class B Placement Agent Warrants, with an exercise price of $12,600.00 per share;

47 •194shares of our common stock issuable upon the alternative cashless exercise of the Class C Common Stock Warrants, or 485shares of our common stock upon cash exercise with an exercise price of $16.00 per share; •5,060shares of common stock issuable upon the exercise of the Class D Common Stock Warrants, with an exercise price of $3.85 per share; •64,506shares of common stock issuable upon the exercise of the Class E Common Stock Warrants, with an exercise price of $16.00 per share; •508,006shares of our common stock issuable upon the alternative cashless exercise of the Class F Common Stock Warrants, or 254,003shares of our common stock upon cash exercise with an exercise price of $16.00 per share; •381,004shares of common stock issuable upon the exercise of the Class G Common Stock Warrants, with an exercise price of $3.76 per share; and •shares of common stock issuable upon the exercise of the Common